Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.
Sec. Atherosclerosis and Vascular Medicine
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1471153

Identification of key genes for cuproptosis in carotid atherosclerosis

Provisionally accepted
Xize Wu Xize Wu 1健 康 健 康 2Pan Xue Pan Xue 2Chentian Xue Chentian Xue 3*Jiaxiang Pan Jiaxiang Pan 4*Chao Quan Chao Quan 1*Lihong Ren Lihong Ren 1*Lihong Gong Lihong Gong 4*Yue Li Yue Li 4*
  • 1 Nantong Hospital of Traditional Chinese Medicine, Nantong, China
  • 2 Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China
  • 3 Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China
  • 4 Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China

The final, formatted version of the article will be published soon.

    Background: Atherosclerosis is a leading cause of cardiovascular disease worldwide, while carotid atherosclerosis (CAS) is more likely to cause ischemic cerebrovascular events. Emerging evidence suggests that cuproptosis may be associated with an increased risk of atherosclerotic cardiovascular disease. This study aims to explore the potential mechanisms linking cuproptosis and CAS.The GSE100927 and GSE43292 datasets were merged to screen for CAS differentially expressed genes (DEGs) and intersected with cuproptosis-related genes to obtain CAS cuproptosis-related genes (CASCRGs).Unsupervised cluster analysis was performed on CAS samples to identify cuproptosis molecular clusters.Weighted gene co-expression network analysis was performed on all samples and cuproptosis molecule clusters to identify common module genes. CAS-specific DEGs were identified in the GSE100927 dataset and intersected with common module genes to obtain candidate hub genes. Finally, 83 machine learning models were constructed to screen hub genes and construct a nomogram to predict the incidence of CAS.Results: Four ASCRGs (NLRP3, SLC31A2, CDKN2A, and GLS) were identified as regulators of the immune infiltration microenvironment in CAS. CAS samples were identified with two cuproptosis-related molecular clusters with significant biological function differences based on ASCRGs. 220 common module hub genes and 1518 CAS-specific DEGs were intersected to obtain 58 candidate hub genes, and the machine learning model showed that the Lasso+XGBoost model exhibited the best discriminative performance. Further external validation of single gene differential analysis and nomogram identified SGCE, PCDH7, RAB23, and RIMKLB as hub genes; SGCE and PCDH7 were also used as biomarkers to characterize CAS plaque stability. Finally, a nomogram was developed to assess the incidence of CAS and exhibited satisfactory predictive performance.Cuproptosis alters the CAS immune infiltration microenvironment and may regulate actin cytoskeleton formation.

    Keywords: Atherosclerosis, cuproptosis, unsupervised clustering analysis, Machine learning model, nomogram

    Received: 29 Jul 2024; Accepted: 21 Oct 2024.

    Copyright: © 2024 Wu, 康, Xue, Xue, Pan, Quan, Ren, Gong and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Chentian Xue, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China
    Jiaxiang Pan, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China
    Chao Quan, Nantong Hospital of Traditional Chinese Medicine, Nantong, China
    Lihong Ren, Nantong Hospital of Traditional Chinese Medicine, Nantong, China
    Lihong Gong, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China
    Yue Li, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.